AMAT vs NRIX · P/E 56, rev $28.37B vs rev $54.5M
Applied Materials Inc (AMAT) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2025-10-26 was $28.37B. Net income was $7.00B. Revenue was up 4.4% from 2024-10-27 to 2025-10-26. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the AMAT and NRIX stock pages for the full models.
Not investment advice.